PERINDOPRIL-TAV perindopril arginine 2.5mg tablet bottle

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

perindopril arginine, Quantity: 2.5 mg

Commercializzato da:

Medis Pharma Pty Ltd

INN (Nome Internazionale):

perindopril arginine

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: sodium starch glycollate type A; maltodextrin; lactose monohydrate; colloidal anhydrous silica; glycerol dibehenate; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350

Via di somministrazione:

Oral

Confezione:

30, 10

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

The treatment of hypertension; The treatment of heart failure. In such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (The safety and efficacy of perindopril arginine has not been demonstrated for New York Heart Association Category IV patients); and Patients with established coronary artery disease (see Clinical Trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Dettagli prodotto:

Visual Identification: White, round, biconvex, film-coated tablets; Container Type: Bottle; Container Material: HDPE; Container Life Time: 6 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2015-08-07